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Abstract
Background: The German Cancer Aid set up a priority re-
search programme with the intention to generate high-
quality information based on evidence and to make this in-
formation easily accessible for health-care professionals and 
advisors, researchers, patients, and the general public. Sum-
mary: The Kompetenznetz Komplementärmedizin in der 
Onkologie (KOKON) received 2 funding periods within this 
programme. During the first funding period, KOKON as-
sessed patients’ and health-care professionals’ information-
al needs, developed a consulting manual for physicians, de-
veloped an education programme for self-help groups, set 
up a knowledge database, and developed a pilot informa-
tion website for patients. Funding period 2 continues with 
work that allows cancer patients and health-care profession-
als to make informed decisions about complementary and 
alternative medicine (CAM). For this aim, KOKON evaluates 
training programmes for physicians (oncology physicians, 
paediatric oncologists, and general practitioners) and for 
self-help groups. All training programmes integrate results 
from an analysis of the ethical, psychological, and medical 
challenges of CAM in the medical encounter, and the knowl-
edge database is being extended with issues related to CAM 
for supportive and palliative care. Key Message: A Germany-
wide collaborative research project to identify needs, pro-
vide information, foster communication, and support deci-
sion-making about CAM in oncology is being set up.
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KOKON: Ein deutschlandweites 
Verbundforschungsprojekt, um Bedarf bezüglich 
Komplementärmedizin in der Onkologie zu 
identifizieren, entsprechende Informationen zur 
Verfügung zu stellen sowie Kommunikation und 
Entscheidungsfindung zu befördern
Schlüsselwörter
Komplementärmedizin · Onkologie · Information and 
Kommunikation
Zusammenfassung
Hintergrund: Die Deutsche Krebshilfe hatte ein soge-
nanntes “Priority Research Programme” ausgeschrieben, 
in dem evidenzbasierte Informationen von höchster Qua-
lität für Angehörige von Gesundheitsberufen und für  
Berater, Forscher, Patienten und die Öffentlichkeit zu-
gänglich gemacht werden sollten. Zusammenfassung: 
Das Kompetenznetz Komplementärmedizin in der Onko-
logie (KOKON) konnte Fördergelder für zwei Förderperi-
oden innerhalb dieses Programms akquirieren. KOKON 
untersuchte in der ersten Förderperiode den Bedarf von 
Patienten und Angehörigen von Gesundheitsberufen 
sowie Informationsbedürfnisse, entwickelte ein Konsulta-
tionsmanual für Ärzte, ein Trainingsprogramm für Selbst-
hilfegruppen, baute eine Wissensdatenbank auf und ent-
wickelte eine Pilot-Informations-Webseite für Patienten. 
In Förderperiode 2 wurde diese Arbeit insofern fortge-
setzt, als dass Patienten und Angehörige von Gesund-
heitsberufen in die Lage versetzt werden sollten, infor-
mierte Entscheidungen zu treffen. Zu diesem Zweck eva- 
luiert KOKON Trainingsprogramme für Ärzte (aus der 
Onkologie, Kinderonkologen und Hausärzte) und für  
Selbsthilfe-Gruppen. Alle Trainingsprogramme integrie-
ren Ergebnisse von Analysen der ethischen, psycholo-
gischen und medizinischen Herausforderungen von Kom-
plementärmedizin in der medizinischen Versorgung, und 
die Wissensdatenbank wird um Themen der Supportiv- 
und der Palliativ-Therapie erweitert. Schlussfolgerung: 
Ein deutschlandweiter Forschungsverbund konnte eta-
bliert werden, um den Bedarf bezüglich Komplementär-
medizin in der Onkologie zu identifizieren, entsprechende 
Informationen zur Verfügung zu stellen sowie Kommuni-
kation und Entscheidungsfindung zu fördern.
© 2019 S. Karger AG, Basel
Introduction
Complementary and alternative medicine (CAM) is 
highly prevalent among cancer patients. A meta-analysis 
of epidemiological studies has shown that the prevalence 
of CAM use in cancer patients has increased steadily from 
25% in the 1980s to more than 49% since 2000 [1]. Simi-
larly high rates can be found in paediatric oncology: de-
pending on the study population and how CAM is de-
fined, 12–85% of children are treated with it [2].
From the patient perspective, it is possible to distin-
guish between “push” and “pull” factors of CAM [3]. Pull 
factors include valuing CAM as a natural approach in 
which patients can play an active role, the sheer availabil-
ity of CAM options, boosting of the immune system, re-
duction of the side effects of conventional treatment, and 
the belief that CAM can support both physical and psy-
chological health [4].
In contrast, Wanchai et al. [5] identified perceived in-
effectiveness and concerns about possible negative effects 
of standard treatment as well as unsatisfactory communi-
cation with doctors as push factors for CAM use in wom-
en with breast cancer. Taking those factors together, pa-
tients have a considerable need for information and guid-
ance but often get frustrated about the diverging 
information and contradictory messages about the evi-
dence of CAM [6]. Although patients want health profes-
sionals to be their primary point of contact for informa-
tion and guidance about CAM, helpful communication is 
rare in the clinical encounter, in adult as well as in paedi-
atric oncology [4, 7, 8].
A systematic review of guidelines seeking to explain 
how doctors should discuss CAM with their patients 
came up with the following recommendations: (1) elicit 
the person’s understanding of their situation; (2) respect 
cultural and linguistic diversity and different epistemo-
logical frameworks; (3) ask questions about CAM use at 
critical points in the illness trajectory; (4) explore details 
and listen actively; (5) respond to the person’s emotional 
state; (6) discuss relevant concerns while respecting the 
person’s beliefs; (7) provide balanced, evidence-based ad-
vice; (8) summarize discussions; (9) document the dis-
cussion; (10) monitor and follow up [9]. 
Findings from a clinician-led consultation service 
about CAM, funded by the German Cancer Aid since 
1999, showed that a guideline-oriented, patient-centred 
approach provides physicians with the opportunity to en-
gage in open and supportive dialogues about CAM to 
help with symptom management, psychological support, 
and individual self-care [10]. 
In response to this, the German Cancer Aid initiated the 
priority research programme “Complementary Medicine 
in Oncology” in 2010. The programme was intended to 
“generate high-quality information on existing practices 
and evidence-based studies as well as make this informa-
tion easily accessible for health care professionals and advi-
sors, researchers, patients and the general public.” 
Within this priority programme, 2 grants were award-
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logie (KOKON) from 2012 to 2015 (funding period 1) and 
from 2016 to 2020 (funding period 2). KOKON is a multi-
professional Germany-wide collaborative research proj-
ect with the aim to establish a “Competence Network for 
Complementary Medicine in Oncology.” During funding 
period 1, KOKON consisted of 13 institutions, which suc-
cessfully carried out comprehensive and collaborative 
projects within 6 research areas (Fig. 1) [11]. For the on-
going funding period 2 and its 7 research areas, KOKON 
extended its research network by institutions from paedi-
atric oncology and pharmaceutic biology. In this paper, 
we briefly summarize the key findings from funding pe-
riod 1 and subsequently describe the research programme 
of funding period 2 in more detail. We then discuss what 
KOKON’s results and its multidisciplinary approach 
have contributed to the discussion about CAM in oncol-
ogy, the challenges associated with this topic, and the dif-
ficulties of making resources available for the provision 
of evidence-based and patient-oriented information on 
CAM within standard oncologic care after the termina-
tion of the priority programme.
When it comes to communication projects in this area, 
it is important to say a word about the distinction be-
tween alternative and complementary medicine in the 
sense that it certainly is problematic to use CAM methods 
“as an alternative” to standard therapy (e.g., chemother-
apy). Complementary methods, on the other hand, can be 
seen as less problematic when counteracting symptoms 
but not interfering with standard therapy. However, as 
interactions can apply, one should be cautious as well.
From a communication point of view, we think that 
one should not discourage patients but encourage them 
(e.g., to stay with the standard treatment). In some in-
stances, it can also help to defocus patients from dubious 
methods by not telling them what they should do (e.g., “do 
not use ‘alternative methods’”) but by understanding their 
motivation. As a result, we try to encourage conversations 
about what patients use and why they use what. We be-
lieve that this is the best basis for talking about CAM 
methods and their limits, irrespectively of the distinction 
between alternative and complementary medicine. 
Funding Period 1: Identifying Needs and Providing 
Information
In funding period 1, we set up the basis for information, 
communication, and training through the following: 
Needs Analysis among Patients and Health-Care 
Professionals
We investigated the need for information and com-
munication about CAM in cancer patients by means of a 
media reception analysis [12], qualitative interviews, and 
a quantitative survey [13, 14] and assessed the need for 
information and training about CAM of health-care pro-
fessionals working in oncology (physicians, nurses, psy-
chologists, and social workers) through qualitative inter-
views and a quantitative survey [15, 16]. Taken together, 
the findings underlined the importance which the topic 
CAM has for patients within the cancer journey and re-
vealed a strong need for information and training about 
CAM in health professionals. 
Evaluation of Physician-Led Consultation Services
We advanced the findings of a previous project [10] 
into a communication manual for a multicenter physi-
cian-led consultation service and implemented and eval-
uated the service at 7 cancer centres. Based on the manu-
al, we developed a training programme for gynaecologists 
consulting cancer patients about CAM and tested the 
programme in a pilot randomized study [17]. 
Setup of a Knowledge Database and Information 
Website
To provide evidence-based information on CAM for 
KOKON’s health professionals, we started to set up a 
knowledge database in close cooperation with the CAM-
CANCER project (originally funded by the European 
Commission within the Framework 5 Programme and now 
managed by the Norwegian National Research Center for 
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Complementary and Alternative Medicine [NAFKAM]). 
For the content, we translated, updated, and published the 
monographs of CAM-CANCER on the platform “Onkope-
dia” of the DGHO (https://www.onkopedia.com). We fur-
thermore compiled short summaries on a broad range of 
CAM topics and established a novel system to estimate the 
risk of herb-drug interactions based on a systematic synthe-
sis of the available pharmacologic evidence [18, 19].
For cancer patients, we developed, tested, and launched 
a concept-based pilot version of an information website 
on CAM (https://www.kokoninfo.de). 
Evaluation of an Education Programme for Cancer 
Self-Help Groups
To strengthen and promote the competence of patients 
and relatives dealing with CAM, a modular educational 
programme was developed and tested. The first evaluation 
results indicate that the programme can assist cancer self-
help group leaders in starting a structured discussion 
about CAM in their groups [Jablotschkin et al., in press].
Funding Period 2: Supporting Communication and 
Decision-Making 
In funding period 2, KOKON follows up on the main 
themes developed in funding period 1 and extends its 
work in order to bring it to a level that allows informed 
decision-making about CAM in daily oncology practice. 
For this purpose, KOKON sets up and evaluates training 
programmes for the group of physicians that patients or 
their relatives usually ask for advice (oncology physicians, 
paediatric oncologists, and general practitioners [GPs]) 
and for self-help groups. All training programmes inte-
grate results from an interdisciplinary analysis of the eth-
ical, psychological, and medical challenges of CAM in the 
medical encounter. KOKON furthermore extends the 
knowledge database according to the results of the needs 
assessment in health-care professionals in funding period 
1. Similarly to funding period 1, KOKON consists of a 
multi-professional research team to meet the peculiarities 
of the research field with experts from oncology, general 
medicine, paediatrics, epidemiology, pharmacology, psy-
chology, and medical ethics. Altogether, 7 projects are be-
ing carried out in 4 major research areas: (1) communica-
tion and decision-making, (2) training, (3) knowledge da-
tabase, and (4) cancer self-help organizations (Fig. 2).
Topic 1: Communication and Decision-Making
This is a multi-professional project that involves on-
cology physicians, psychologists, and experts on medical 
ethics. The overall aim is to help oncologists, GPs, and 
paediatric oncologists to deal with advice being requested 
relating to CAM in a professional manner. For this pur-
pose, conceptual as well as empirical research was con-
ducted. Theoretical analysis focused on descriptive and 
normative criteria with which CAM is usually labelled 
and associated. Empirical research is used to explore 
health professionals’ perceptions and views of the chal-
lenges they face when dealing with CAM in cancer. Based 
on this conceptual and empirical research, an interdisci-
plinary analysis of the ethical, psychological, and medical 
challenges of CAM is being conducted. Findings are used 
to develop concepts for communication and decision-
making about CAM and to conduct workshops to train 
physicians. The project furthermore develops institution-
al strategies to deal with CAM in cancer care.
Topic 2: Training Programmes 
(a) Training Programme for Oncology Physicians
A blended-learning training programme (KOKON-
KTO) consisting of nine 45-min e-learning units and a 
2-day on-site skills workshop has been developed with 
the aim of teaching oncology physicians about CAM and 
how to advise their patients on the subject. To evaluate 
the training, 40 physicians will take part in a cluster-ran-
domized trial, of whom some will have undergone the 
KOKON-KTO training and some will not. Within the 
study, physicians will each advise up to 10 patients. Ef-
fectiveness will be evaluated within 3 settings: after e-
learning, during skills training, and after physicians have 
provided advice to their patients [20].
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(b) Training Programme for Paediatric Oncologists
Similarly to the training for oncology physicians, this 
training consists of a blended-learning programme (e-
learning modules and on-site skills training in which typ-
ical CAM consulting situations in paediatric oncology 
and in standard practice are simulated and discussed). 
The content of the e-learning materials is based on a sur-
vey of the training needs of paediatric oncologists. The 
content of the e-learning training modules was developed 
in cooperation with the other project groups within topic 
2 and was supplemented with specific information relat-
ing to paediatric oncology. For this purpose, the scien-
tific database KOKONbase that was developed in the first 
funding period has been updated with specific child in-
formation on paediatric oncology. The blended learning 
training will be evaluated by surveys and by studying 
communication situations using the Roter Interaction 
Analysis system [21]. 
(c) Training Programme for GPs
A blended-learning training programme for GPs has 
been developed together with the other groups and was 
adapted to the needs of GPs. It consists of e-learning 
modules that provide an overview of what is meant by 
CAM and why patients are interested in it, as well as evi-
dence-based information on treating several core symp-
toms. In contrast to the other training programmes, a 
chapter on oncology treatments is also included. Analo-
gous to the other training programmes, the e-learning 
phase is followed by an on-site skills workshop in which 
communication challenges are discussed and decision-
making is trained on an individual basis. The evaluation 
consists of surveys and also studies communication situ-
ations using the Roter Interaction Analysis system [21].
Topic 3: Knowledge Database
(a) Efficacy and Safety of CAM for Supportive and 
Palliative Care
This project aims to expand the knowledge database 
(KOKONbase) that was developed in the first funding pe-
riod. For this purpose, the project team summarizes and 
synthesizes the best available evidence for CAM interven-
tions for supportive and palliative care. All processes, in-
cluding literature retrieval, appraisal, writing, and re-
viewing, follow systematic, predefined methods. 
(b) Pharmacokinetic and Pharmacodynamic 
Interactions of Herbal Drugs
The aim of this project is to present and estimate in-
teraction potential for a representative spectrum of phy-
totherapeutical plant specimens used in supportive care 
for anticancer treatment. This includes pharmacokinetic 
as well as pharmacodynamic drug interaction mecha-
nisms. The evaluation of pharmacodynamic herb-drug 
interactions will focus on synergistic hepatotoxicity, im-
munomodulation, and antioxidative antagonisms. Fur-
ther, risk estimates are being developed for the use of phy-
totherapeutics in regimens with combinations of anti-
neoplastic drugs. This project is carried out in close 
cooperation with the team evaluating the efficacy and 
safety of complementary medicine procedures for sup-
portive anticancer care that was described in the previous 
paragraph. Each document will be peer-reviewed and 
cross-linked within the KOKON evidence database. 
Through a collaboration with the Deutsche Gesell-
schaft für Hämatologie und Medizinische Onkologie, in-
formation from (a) and (b) will be easily accessible 
through the Onkopedia website (https://www.onkopedia.
com/de/onkopedia/guidelines) and will support all KO-
KON training programmes.
Topic 4: Educational Programme for Self-Help Groups 
Self-help groups in cancer care offer nonprofessional 
psychosocial support to patients and cancer survivors. 
This includes providing information on cancer- and 
treatment-related topics and giving patients the opportu-
nity to share their experiences with cancer and the health-
care system. CAM is one of many topics that is frequent-
ly discussed in self-help groups, but generally under con-
siderable uncertainty with regard to the reliability of 
available information, and with a lack of guidance. The 
educational programme consists of 4 structured modules 
(overview of CAM in cancer, expectations, reliability and 
evidence, sources of information of assured quality). 
Train-the-trainer workshops are used to train group lead-
ers to pass information on to their groups. The aim of this 
project is to implement the programme in cooperation 
with the largest cancer patient advocacy groups in Ger-
many and to evaluate the training. We evaluate the train-
the-trainer workshops and the educational programmes 
with the group members. To analyse the effects of the 
educational programme, a follow-up assessment is car-
ried out after 6 months. 
Discussion
All projects in funding periods 1 and 2 aim to support 
cancer patients and health professionals to make in-
formed decisions about the use of CAM. To achieve this 
aim, a number of challenges must be overcome. We would 
like to discuss 3 aspects that are of relevance: 
1. Multi- and Interdisciplinarity: What Is Required to 
Make Informed Decisions about CAM? 
Work in KOKON draws from the expertise of a num-
ber of disciplines, such as oncology, epidemiology, paedi-
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dia. Such a multi-professional approach is clearly neces-
sary to ensure that information provided on CAM in 
cancer care is well founded and to support informed de-
cision-making on the subject in the future. While, for ex-
ample, the development of a sound evidence base for 
CAM treatments requires the work of pharmacologists, 
clinical experts, and epidemiologists, the expertise of cli-
nicians from a number of fields is necessary to develop 
trainings that take into account the particular contexts, 
needs, and perspectives of physicians specializing in dif-
ferent areas. Expertise in psychology and ethics helps the 
developers of training programmes to reflect critically 
upon the normative and communication requirements of 
such programmes, and collaboration with self-help 
groups fosters empowerment and self-care.
While experiences gathered in KOKON have shown 
that the best results are achieved when a multidisciplinary 
team works on the communication of CAM options in on-
cology, some challenges remain. This is because patients, 
relatives, representatives of self-help groups, and various 
medical disciplines have their own attitudes, needs, and 
wishes and are not always satisfied with information for 
which only scanty evidence exists. For this reason, all com-
munication and training concepts, as well as the knowledge 
database (KOKONbase) and the information platform 
(KOKONinfo), explicitly account for communication 
challenges in everyday practice and give practical informa-
tion that is always based on the best available evidence. 
However, whether patients benefit sufficiently from these 
concepts and trainings requires further investigation. 
2. Translation: From the Identification of Needs to the 
Implementation and Evaluation of Effective Training
In addition and complementary to cancer patients’ in-
terest in receiving advice on CAM options, the KOKON 
network has explored the informational needs of health 
professionals engaged in cancer care [12, 15] and set up a 
pilot training programme accordingly [17]. The analysis 
of needs in the first funding period showed that it is nec-
essary to provide health-care personnel and self-help 
groups with scientifically sound information on CAM 
treatments for cancer patients [15]. Sound information 
would address doctors’ desire to have at their fingertips 
an overview of different CAM options for supportive and 
palliative cancer care. As patients’ needs and attitudes are 
often influenced by the media, sound information might 
also help provide a more accurate picture of what CAM 
is and what it can be expected to achieve. However, in or-
der to provide good quality information through the KO-
KON network, it was necessary to prepare structured sci-
entific texts on treatment methods used in complemen-
tary medicine and provide evidence-based information 
on interactions between herbal substances and cancer 
medications. This was carried out in both the first and 
second funding periods and has led to the preparation of 
hundreds of texts on various substances and treatment 
options. Qualitative interviews conducted in the first 
funding period also made it clear that advising cancer pa-
tients on CAM is not solely a question of synthesizing 
available evidence but also presents doctors with impor-
tant ethical and communicative challenges [16]. 
The translation of identified needs into support for 
health professionals and patients in clinical practice is the 
central aim of the second funding period. The develop-
ment of blended-learning programmes that consist of e-
learning sessions and on-site workshops for oncology 
physicians, paediatric oncologists, and GPs requires the 
support of experts in the field, not only to identify the 
most important and relevant questions but also to provide 
high-quality training that is acceptable and interesting 
from the perspective of those working in the field. At the 
same time, KOKON’s blended-learning programmes ex-
plicitly address the so-called communication gap of CAM 
in oncology [22]. In addition, the knowledge base includ-
ing practical comments on how to interpret scarce evi-
dence in the literature can be used to develop e-learning 
materials for upcoming training programmes. All training 
courses are currently being evaluated with respect to 
knowledge gain and communication skills. The cluster-
randomized pilot trial from the first phase showed that 
training oncology physicians in providing advice during 
CAM-designated consultations scores highly for patient 
satisfaction and may be especially beneficial for physicians 
less experienced in CAM. However, physicians have re-
ported that an additional consultation of around 45 min 
about CAM is too time-consuming [17]. The second will 
address this issue and train oncology physicians for a con-
sultation format that fits better into everyday practice.
3. Sustainability: How to Ensure the Implementation 
of KOKON’s Results in Daily Practice 
Providing sustainable resources for informed decision-
making on questions relating to CAM requires structures 
and processes that can exist independently of current fund-
ing. Currently, all projects develop their own strategies and 
formats to ensure sustainability, while taking into account 
their own specific requirements, e.g., the information base 
must be continuously updated to reflect new evidence as it 
emerges. This means that staff will be required to review 
new evidence, provide technical support, and update on-
line materials. A different strategy is necessary for the train-
ing modules. There are different ways to achieve sustain-
ability, such as by making the education manuals for the 
training programmes generally accessible (e.g., through 
professional associations) and by offering the training pro-
grammes as options in continuing medical education. 
Training programmes for oncology physicians and nurses 
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